Table 4.
Non-Oral Modes of Administration | Frequency (%) |
---|---|
Insulin Injections | 11 (5.6%) |
Eye Drops | 26 (13.1%) |
Inhaler/Nebulizer Therapy | 19 (9.6%) |
Any of the above | 50 (25.3%) |
Additional Monitoring Required | |
Diabetes therapy | 29 (14.6%) |
Cancer therapy | 7 (3.5%) |
Prednisone | 3 (1.5%) |
Seizure Disorder | 24 (12.1%) |
Digoxin | 27 (13.6%) |
Thyroid | 32 (16.2%) |
Warfarin Therapy | 15 (7.6%) |
Any of the above | 98 (49.5%) |